Strategically Plan, Launch & Scale Global Early Access Programmes to Deliver Earlier Patient Access While Navigating Complex Regulatory, Supply & Operational Hurdles
Early Access Programmes have evolved into a critical, but increasingly complex, part of drug development and launch strategy. What was once a reactive pathway is now a strategic lever shaping timelines, evidence generation, and patient access across global markets.
As regulatory expectations intensify, reimbursement timelines stretch and programmes expand across more regions, the need for smarter, earlier and more operationally robust access strategies has never been greater.
That is why the 5th Operationalise: Early Access Programmes Summit Europe has become the essential meeting point for the teams leading this transformation. We'll be bringing together 140+ experts across Medical Affairs, Patient Access, Regulatory, Clinical Operations, Supply and Evidence Generation to define what best-in-class early access looks like in 2026 and beyond.
Hear directly from senior leaders at UCB, Eisai, Novartis, BeOne Medicines, Alnylam Pharmaceuticals, Genmab, AstraZeneca, Bristol Myers Squibb, Argenx, ACADIA Pharmaceuticals, and more as they share the decisions, frameworks and lessons shaping the next generation of Early Access Programmes.
Whether you are building your first programme, scaling across regions, or managing a global access portfolio, this is your opportunity to benchmark against the organisations setting the pace globally.
It was inspiring to see such a broad spectrum of expertise come together in one forum, fostering meaningful dialogue and actionable insights
Associate Director & Co-Ordinator, Early Access Care
The open exchange of best practices among high caliber experts in the fields is a standard in this conference series. The prominent presence of the patient caregivers is reminding us all why it is important to work and continuing building this space
Patient Access Programme & Supply Lead, Roche
Valuable information sharing via well experienced speakers and open discussions both on best but also worst practices…
EAP & Patient Support Services Director, ACADIA Pharmaceuticals
Explore the Full Event Guide
- Get a Full Overview of the Agenda, Speakers, and Session Topics in One Place
- Share Easily With Your Team to Assess and Mobilise Interest
- Discover Unrivalled Networking Opportunities With 140+ Leaders Across Medical Affairs, Regulatory, Clinical Operations, and Supply
- Explore Attendee Benefits, Exclusive Event Insights and Anticipated Audience Metrics
- Learn More About Europe’s Only Forum Dedicated to the Operational Reality of Early Access
2026 Partners
Attending Companies
Explore Related Events
Explore the Agenda
Discover exactly how leading teams are solving the hardest Early Access challenges - from pathway selection and global delivery to data, supply, and long-term sustainability.
Partner With Us
Position your solutions in front of decision-makers actively looking to scale and optimise Early Access Programmes, and become a trusted partner in delivering access worldwide.
Join Early Access Leaders
Connect with the EAP community shaping how access is delivered today, exchange real challenges, and learn directly from peers running programmes across global markets.